{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:15:22Z","timestamp":1792746922779,"version":"4.5.0"},"reference-count":56,"publisher":"BMJ","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"accepted":{"date-parts":[[2023,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To test for potential non-specific effects of an additional, early measles, mumps, and rubella (MMR) vaccine at age 5-7 months on risk of infection related hospitalisation before age 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Randomised, double blinded, placebo controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Denmark, a high income setting with low exposure to MMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>6540 Danish infants aged 5 to 7 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Infants were randomly allocated 1:1 to intramuscular injection with standard titre MMR vaccine (M-M-R VaxPro) or placebo (solvent only).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>\n                      Hospitalisations for infection, defined as all hospital contacts of infants referred from primary care for hospital evaluation and with an infection diagnosed, analysed as recurrent events, from randomisation to 12 months of age. In secondary analyses implications of censoring for date of subsequent diphtheria, tetanus, pertussis, polio,\n                      <jats:italic>Haemophilus influenzae<\/jats:italic>\n                      type B, and immunisation with pneumococci conjugate vaccine (DTaP-IPV-Hib+PCV), potential effect modification by sex, prematurity (&lt;37 weeks\u2019 gestation), season, and age at randomisation were tested, and the secondary outcomes of hospitalisations \u226512 hours and antibiotic use were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>6536 infants were included in the intention-to-treat analysis. 3264 infants randomised to MMR vaccine experienced 786 hospitalisations for infection before age 12 months compared with 762 for the 3272 infants randomised to placebo. In the intention-to-treat analysis the rate of hospitalisations for infection did not differ between the MMR vaccine and placebo groups (hazard ratio 1.03, 95% confidence interval 0.91 to 1.18). For infants randomised to MMR vaccine compared with those randomised to placebo, the hazard ratio of hospitalisations for infection with a duration of at least 12 hours was 1.25 (0.88 to 1.77), and for prescriptions of antibiotics was 1.04 (0.88 to 1.23). No significant effect modifications were found by sex, prematurity, age at randomisation, or season. The estimate did not change when censoring at the date infants received DTaP-IPV-Hib+PCV after randomisation (1.02, 0.90 to 1.16).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Findings of this trial conducted in Denmark, a high income setting, do not support the hypothesis that live attenuated MMR vaccine administered early to infants aged 5-7 months decreases the rate of hospitalisations for non-targeted infection before age 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      EU Clinical Trials Registry EudraCT 2016-001901-18 and ClinicalTrials.gov\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03780179\">NCT03780179<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmj-2022-072724","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T08:36:05Z","timestamp":1686126965000},"page":"e072724","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial"],"prefix":"10.1136","volume":"381","clinical-trial-number":[{"clinical-trial-number":"nct03780179","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9872-6608","authenticated-orcid":false,"given":"Anne Cathrine","family":"Zimakoff","sequence":"first","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Danish National University Hospital \u201cRigshospitalet,\u201d Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Danish National University Hospital \u201cRigshospitalet,\u201d Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe Maria","family":"Vittrup","sequence":"additional","affiliation":[{"name":"Child and Adolescent Department, University Hospital Herlev, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Hoppe","family":"Herlufsen","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Kiehn","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Danish National University Hospital \u201cRigshospitalet,\u201d Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Malon","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Danish National University Hospital \u201cRigshospitalet,\u201d Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannet","family":"Svensson","sequence":"additional","affiliation":[{"name":"Child and Adolescent Department, University Hospital Herlev, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone Graff","family":"Stensballe","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Danish National University Hospital \u201cRigshospitalet,\u201d Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"2025110102100188000_381.jun07_2.e072724.1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(21)00311-4"},{"key":"2025110102100188000_381.jun07_2.e072724.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(84)93192-X"},{"key":"2025110102100188000_381.jun07_2.e072724.3","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115086"},{"key":"2025110102100188000_381.jun07_2.e072724.4","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117688"},{"key":"2025110102100188000_381.jun07_2.e072724.5","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91771-L"},{"key":"2025110102100188000_381.jun07_2.e072724.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(09)90015-4"},{"key":"2025110102100188000_381.jun07_2.e072724.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7003.481"},{"key":"2025110102100188000_381.jun07_2.e072724.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5170"},{"key":"2025110102100188000_381.jun07_2.e072724.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13771-3"},{"key":"2025110102100188000_381.jun07_2.e072724.10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit804"},{"key":"2025110102100188000_381.jun07_2.e072724.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.071"},{"key":"2025110102100188000_381.jun07_2.e072724.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c6495"},{"key":"2025110102100188000_381.jun07_2.e072724.13","first-page":"761","article-title":"Sex-specific differences in mortality after high-titre measles immunization in rural Senegal","volume":"72","author":"Aaby","year":"1994","journal-title":"Bull World Health Organ"},{"key":"2025110102100188000_381.jun07_2.e072724.14","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800057836"},{"key":"2025110102100188000_381.jun07_2.e072724.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(96)90275-8"},{"key":"2025110102100188000_381.jun07_2.e072724.16","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200202000-00006"},{"key":"2025110102100188000_381.jun07_2.e072724.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2007.00537.x"},{"key":"2025110102100188000_381.jun07_2.e072724.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.10.007"},{"key":"2025110102100188000_381.jun07_2.e072724.19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw512"},{"key":"2025110102100188000_381.jun07_2.e072724.20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu354"},{"key":"2025110102100188000_381.jun07_2.e072724.21","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-016-0738-z"},{"key":"2025110102100188000_381.jun07_2.e072724.22","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix042"},{"key":"2025110102100188000_381.jun07_2.e072724.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.104"},{"key":"2025110102100188000_381.jun07_2.e072724.24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1033"},{"key":"2025110102100188000_381.jun07_2.e072724.25","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa091"},{"key":"2025110102100188000_381.jun07_2.e072724.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.01.096"},{"key":"2025110102100188000_381.jun07_2.e072724.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004328"},{"key":"2025110102100188000_381.jun07_2.e072724.28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac155"},{"key":"2025110102100188000_381.jun07_2.e072724.29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.85.2.188"},{"key":"2025110102100188000_381.jun07_2.e072724.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101467"},{"key":"2025110102100188000_381.jun07_2.e072724.31","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1663119"},{"key":"2025110102100188000_381.jun07_2.e072724.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332"},{"key":"2025110102100188000_381.jun07_2.e072724.33","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04845-7"},{"key":"2025110102100188000_381.jun07_2.e072724.34","unstructured":"Danish Health Authority . The Danish childhood vaccination programme: 2018. Danish Health Authority, 2018."},{"key":"2025110102100188000_381.jun07_2.e072724.35","unstructured":"Summary of product characteristics. M-M-RVaxPro. European Medicines Agency. 2018. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/m-m-rvaxpro-epar-product-information_en.pdf (accessed 8 Sep 2019)."},{"key":"2025110102100188000_381.jun07_2.e072724.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2025110102100188000_381.jun07_2.e072724.37","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00044-3"},{"key":"2025110102100188000_381.jun07_2.e072724.38","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811401482"},{"key":"2025110102100188000_381.jun07_2.e072724.39","unstructured":"World Health Organization. ICD-10: international statistical classification of diseases and related health problems\u202f: tenth revision. WHO, 2004. https:\/\/apps.who.int\/iris\/handle\/10665\/42980 (accessed 16 May 2022)."},{"key":"2025110102100188000_381.jun07_2.e072724.40","unstructured":"Patientregistrering - LPR3 - Sundhedsdatastyrelsen. https:\/\/sundhedsdatastyrelsen.dk\/da\/rammer-og-retningslinjer\/om-patientregistrering\/indberetning-lpr3 (accessed 25 Jun 2022)."},{"key":"2025110102100188000_381.jun07_2.e072724.41","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piy029"},{"key":"2025110102100188000_381.jun07_2.e072724.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.04.055"},{"key":"2025110102100188000_381.jun07_2.e072724.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.097"},{"key":"2025110102100188000_381.jun07_2.e072724.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.006"},{"key":"2025110102100188000_381.jun07_2.e072724.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.11.021"},{"key":"2025110102100188000_381.jun07_2.e072724.46","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2022.46.15"},{"key":"2025110102100188000_381.jun07_2.e072724.47","doi-asserted-by":"publisher","DOI":"10.3390\/v14020425"},{"key":"2025110102100188000_381.jun07_2.e072724.48","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1997034"},{"key":"2025110102100188000_381.jun07_2.e072724.49","doi-asserted-by":"publisher","DOI":"10.1177\/1403494819850430"},{"key":"2025110102100188000_381.jun07_2.e072724.50","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2769"},{"key":"2025110102100188000_381.jun07_2.e072724.51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6915.1308"},{"key":"2025110102100188000_381.jun07_2.e072724.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2017.12.001"},{"key":"2025110102100188000_381.jun07_2.e072724.53","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010067"},{"key":"2025110102100188000_381.jun07_2.e072724.54","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys223"},{"key":"2025110102100188000_381.jun07_2.e072724.55","unstructured":"World Health Organization. Routine Immunization. WHO. https:\/\/www.who.int\/immunization\/policy\/Immunization_routine_table2.pdf?ua=1 (accessed 8 Sep 2019)."},{"key":"2025110102100188000_381.jun07_2.e072724.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.034"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2022-072724","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2022-072724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:10:08Z","timestamp":1761988208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2022-072724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":56,"alternative-id":["10.1136\/bmj-2022-072724"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2022-072724","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]}}}